Anas Chalah, PhD
Lecturer on Engineering Sciences, Harvard University
Anas Chalah is the executive director of active learning at the John A. Paulson School of Engineering and Applied Sciences (SEAS) at Harvard University, overseeing undergraduate teaching laboratories, and mechanical and electronic student machine shops. Chalah is a member of the SEAS Executive Research and Teaching Team, and a lecturer on engineering sciences. Chalah is an active member of Harvard's Teaching and Learning Consortium, which provides policy recommendations on substantive issues of teaching and learning as well as academic strategic planning.
At SEAS, Chalah leads a team of engineers and faculty to enrich and broaden the intellectual landscape in a variety of areas of active learning including mechanical, electrical, biological, and environmental engineering education, as well as applied physics and applied math. In the process, Chalah and his team work with faculty to develop and implement new course lab components, training students and teaching fellows on the use of good design and engineering practices, as well as advising and assisting students with their junior and senior design projects.
Chalah received his doctoral degree in chemistry from the University of Massachusetts, Amherst. His did his graduate thesis on revealing the mechanism by which bacterial sensing and cell signaling is amplified. He joined Harvard Medical School/Beth Israel Deaconess Medical Center where his postdoctoral work focused on cancer biology and signaling to understand the mechanism by which cancer cells are able to switch between cellular survival and programmed death pathways. Prior to Harvard Medical School, Chalah served as the senior director of the undergraduate teaching laboratories at the University of Massachusetts Chemistry Department. While earning his PhD, Chalah directed six undergraduate teaching labs and supervised the teaching staff.
- PhD University of Massachusetts, Amherst
Courses with Anas Chalah
Spring Term 2018
This course describes the emerging role of nanostructures in drug development activities. It covers the most current nanotechniques applied by the pharmaceutical industry to engineer shuttling mechanisms for delivering previously failed drug molecules.
Advancements in the study of microfluidic components and systems have created a new class of tools and devices. These devices are convenient platforms to study chemical and biochemical analysis and, as a consequence, applications in biology have been on the rise. In this course we introduce the science and technology of miniaturization and its applications in creating microfluidic devices.
Fall term 2017
Nanobiotechnology is a new frontier for biology with important applications in medicine. It bridges areas in physics, chemistry, and biology and is a testament to the new areas of interdisciplinary science that are becoming dominant in the twenty-first century.